Cooley, Kirkland Lead $1.5B Jazz Pharma Deal For Celator
Irish drugmaker Jazz Pharmaceuticals PLC said Tuesday that it has agreed to purchase oncology outfit Celator Pharmaceuticals Inc. for about $1.5 billion in cash, in a deal guided by Cooley LLP...To view the full article, register now.
Already a subscriber? Click here to view full article